Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
400 CHF | +388.82% |
|
-.--% | -.--% |
07-01 | Merck, Orion Convert Ongoing Collaboration Into Exclusive Global License for Opevesostat | MT |
07-01 | Merck: license agreement with Orion Corp. for opevesostat | CF |